Table 1.
Concentrations of malondialdehyde, total antioxidant status and iron body status indices in healthy controls and patients with pulmonary tuberculosis before and after therapy
| Parameters | Control (n = 50) | TB cases (n = 40) | |
|---|---|---|---|
| Before therapy | After therapy | ||
| MDA (μmol/l) | 1.24 ± 0.17 | 3.18 ± 0.58*** | 2.82 ± 0.60***§§§ |
| TAS (mmol/l) | 1.86 ± 0.30 | 1.06 ± 0.12*** | 1.27 ± 0.11***§§§ |
| Iron (μg/dl) | 99.12 ± 27.5 | 55.73 ± 16.78*** | 76.95 ± 28.29***§§§ |
| TIBC (μg/dl) | 397.1 ± 68.5 | 394.8 ± 148.7 | 376.7 ± 136.0 |
| Transferrin saturation % | 25.58 ± 8.4 | 15.89 ± 7.0*** | 21.37 ± 8.7*§§§ |
| Ferritin (ng/ ml) | 183.1 ± 65.6 | 441.76 ± 319.4*** | 185.64 ± 129.1 §§§ |
Note: Results are expressed as mean ± SD
Legend: MDA = malondialdehyde;
***
Significant difference from control at P <0.001; TAS = total antioxidant status;
§§§
Significant difference from before at P <0.001; TIBC = serum iron, total iron binding capacity;
*
Significant difference from control at P <0.05.